AIM
TAK icon

Anchor Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

Anchor Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-145
Closed -$2.59K – 953
2020
Q3 		$2.59K Hold
145
– – ﹤0.01% 789
2020
Q2 		$2.6K Hold
145
– – ﹤0.01% 765
2020
Q1 		$2.2K Hold
145
– – ﹤0.01% 754
2019
Q4 		$2.86K Sell
145
-70
-33% -$1.34K ﹤0.01% 749
2019
Q3 		$3.7K Sell
215
-145
-40% -$2.51K ﹤0.01% 720
2019
Q2 		$6.37K Hold
360
– – ﹤0.01% 668
2019
Q1 		$7.33K Buy
+360
New +$7.24K ﹤0.01% 652

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

Anchor Investment Management's TAK Position: Q4 2020 in Review

Anchor Investment Management sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 145 shares — an estimated $2.59K sold.

Anchor Investment Management first reported a position in TAK in Q1 2019 and held it in 7 quarters. The position peaked at $7.33K in Q1 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

  • Anchor Investment Management reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Anchor Investment Management sold 145 Takeda Pharmaceutical shares in Q4 2020, an estimated $2.59K.
  • Anchor Investment Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 7 quarters.
  • Anchor Investment Management's Takeda Pharmaceutical position peaked at $7.33K in Q1 2019.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on Anchor Investment Management's 13F filing for Q4 2020, filed 2 Jan 2024.